2005 Competition Pharmacology 
European Pharmaceutical Review
OCTOBER 19, 2022
2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” Patents are often described as the ‘lifeblood’ of pharmaceutical companies.
European Pharmaceutical Review
JULY 4, 2024
4,6 Traditional Herbal Registration The Traditional Herbal Medicines Directive (Directive 2004/24/EC) is implemented in the UK by the Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005 and came into force on 30 April 2011. 2005 [cited 2024May]. 2012/1916). Available from: [link] Barber S.
Expert insights. Personalized for you.
96 
Let's personalize your content